Benefits and harms of atypical antipsychotics for agitation in adults with dementia

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Benefits and harms of atypical antipsychotics for agitation in adults with dementia
Authors
Keywords
Evidence-based medicine, Quality of evidence, Atypical antipsychotics, Aripiprazole, Risperidone, Olanzapine, Quetiapine
Journal
EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 27, Issue 3, Pages 217-231
Publisher
Elsevier BV
Online
2017-01-20
DOI
10.1016/j.euroneuro.2017.01.002

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.